These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 9812933)

  • 1. Initiating angiotensin converting enzyme inhibitors in mild to moderate heart failure in general practice: randomised, placebo controlled trial.
    Lough M; Cleland J; Langan J; Cowley A; Wade A
    BMJ; 1998 Nov; 317(7169):1352-3. PubMed ID: 9812933
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinical consequences of angiotensin-converting enzyme inhibitor withdrawal in chronic heart failure: a double-blind, placebo-controlled study of quinapril. The Quinapril Heart Failure Trial Investigators.
    Pflugfelder PW; Baird MG; Tonkon MJ; DiBianco R; Pitt B
    J Am Coll Cardiol; 1993 Nov; 22(6):1557-63. PubMed ID: 8227822
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A multicentre, double-blind, placebo-controlled trial of quinapril in mild, chronic heart failure.
    Northridge DB; Rose E; Raftery ED; Lahiri A; Elder AT; Shaw TR; Henderson E; Dargie HJ
    Eur Heart J; 1993 Mar; 14(3):403-9. PubMed ID: 8458362
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Angiotensin converting enzyme inhibition restores cardiac and hormonal responses to volume overload in patients with dilated cardiomyopathy and mild heart failure.
    Volpe M; Tritto C; DeLuca N; Rubattu S; Mele AF; Lembo G; Enea I; deCampora P; Rendina V; Romano M
    Circulation; 1992 Dec; 86(6):1800-9. PubMed ID: 1451252
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Does blood pressure reduction necessarily compromise cardiac function or renal hemodynamics? Effects of the angiotensin-converting enzyme inhibitor quinapril.
    Kjeldsen SE; Gupta RK; Krause L; Weder AB; Julius S
    Am Heart J; 1992 May; 123(5):1433-8. PubMed ID: 1575171
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quinapril in chronic heart failure.
    Northridge DB; Dargie HJ
    Am J Hypertens; 1990 Nov; 3(11):283S-287S. PubMed ID: 2261147
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effects of ACE inhibitors on exercise capacity in the treatment of congestive heart failure.
    Riegger GA
    J Cardiovasc Pharmacol; 1990; 15 Suppl 2():S41-6. PubMed ID: 1691406
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Angiotensin-converting enzyme inhibition with quinapril improves endothelial vasomotor dysfunction in patients with coronary artery disease. The TREND (Trial on Reversing ENdothelial Dysfunction) Study.
    Mancini GB; Henry GC; Macaya C; O'Neill BJ; Pucillo AL; Carere RG; Wargovich TJ; Mudra H; Lüscher TF; Klibaner MI; Haber HE; Uprichard AC; Pepine CJ; Pitt B
    Circulation; 1996 Aug; 94(3):258-65. PubMed ID: 8759064
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical pharmacology of quinapril in healthy volunteers and in patients with hypertension and congestive heart failure.
    Sedman AJ; Posvar E
    Angiology; 1989 Apr; 40(4 Pt 2):360-9. PubMed ID: 2539762
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Angiotensin-converting enzyme, quinapril, in treating chronic cardiac failure].
    Gadzhiev AN
    Ter Arkh; 2003; 75(1):51-5. PubMed ID: 12652958
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quinapril versus atenolol in the treatment of mild to moderate essential hypertension.
    Bahena JH; Estrella ME; Muñoz M
    Clin Ther; 1992; 14(4):527-36. PubMed ID: 1525787
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparison of the efficacy and safety of quinapril with that of enalapril in the treatment of mild to moderate essential hypertension.
    Taylor SH
    Angiology; 1989 Apr; 40(4 Pt 2):382-8. PubMed ID: 2539763
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Angiotensin-converting enzyme inhibition as antiatherosclerotic therapy: no answer yet. QUIET Investigators. QUinapril Ischemic Event Trial.
    Cashin-Hemphill L; Holmvang G; Chan RC; Pitt B; Dinsmore RE; Lees RS
    Am J Cardiol; 1999 Jan; 83(1):43-7. PubMed ID: 10073783
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The efficacy and safety of quinapril in the treatment of moderate to severe and severe hypertension: comparison to captopril.
    Frishman WH
    Clin Cardiol; 1990 Jun; 13(6 Suppl 7):VII26-31. PubMed ID: 2189618
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quinapril: a double-blind, placebo-controlled trial in essential hypertension.
    Maclean D
    Angiology; 1989 Apr; 40(4 Pt 2):370-81. PubMed ID: 2650581
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The QUinapril Ischemic Event Trial (QUIET) design and methods: evaluation of chronic ACE inhibitor therapy after coronary artery intervention.
    Texter M; Lees RS; Pitt B; Dinsmore RE; Uprichard AC
    Cardiovasc Drugs Ther; 1993 Apr; 7(2):273-82. PubMed ID: 8357782
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The treatment of mild to moderate hypertension with ACE inhibitors.
    Taylor SH
    J Cardiovasc Pharmacol; 1990; 15 Suppl 2():S24-8. PubMed ID: 1691403
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heart failure development in rats with ascending aortic constriction and angiotensin-converting enzyme inhibition.
    Turcani M; Rupp H
    Br J Pharmacol; 2000 Aug; 130(7):1671-7. PubMed ID: 10928973
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quinapril for coronary artery disease.
    Seth S; Mohan A
    Natl Med J India; 1997; 10(2):73-4. PubMed ID: 9153985
    [No Abstract]   [Full Text] [Related]  

  • 20. Effect of treatment on survival in an animal model of chronic heart failure.
    Bastien N; Lambert C
    Am J Cardiol; 1998 Nov; 82(10A):50S-52S. PubMed ID: 9860360
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.